Pharma Mar SA banner

Pharma Mar SA
OTC:PHMMF

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
OTC:PHMMF
Watchlist
Price: 88.72 USD Market Closed
Market Cap: $1.6B

Wall Street
Price Targets

PHMMF Price Targets Summary
Pharma Mar SA

Wall Street analysts forecast PHMMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHMMF is 113.05 USD with a low forecast of 66.22 USD and a high forecast of 142.68 USD.

Lowest
Price Target
66.22 USD
25% Downside
Average
Price Target
113.05 USD
27% Upside
Highest
Price Target
142.68 USD
61% Upside
Pharma Mar SA Competitors:
Price Targets
STG
Strip Tinning Holdings PLC
137% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-9% Downside

Revenue
Forecast

0% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
0% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

For the last 13 years the compound annual growth rate for Pharma Mar SA's revenue is 0%. The projected CAGR for the next 4 years is 23%.

Operating Income
Forecast

-10% / Year
Past Growth
140% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
-10% / Year
Past Growth
140% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Pharma Mar SA's operating income is -10%. The projected CAGR for the next 4 years is 140%.

Net Income
Forecast

14% / Year
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
14% / Year
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Pharma Mar SA's net income is 14%. The projected CAGR for the next 4 years is 63%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHMMF's stock price target?
Price Target
113.05 USD

According to Wall Street analysts, the average 1-year price target for PHMMF is 113.05 USD with a low forecast of 66.22 USD and a high forecast of 142.68 USD.

What is Pharma Mar SA's Revenue forecast?
Projected CAGR
23%

For the last 13 years the compound annual growth rate for Pharma Mar SA's revenue is 0%. The projected CAGR for the next 4 years is 23%.

What is Pharma Mar SA's Operating Income forecast?
Projected CAGR
140%

For the last 13 years the compound annual growth rate for Pharma Mar SA's operating income is -10%. The projected CAGR for the next 4 years is 140%.

What is Pharma Mar SA's Net Income forecast?
Projected CAGR
63%

For the last 13 years the compound annual growth rate for Pharma Mar SA's net income is 14%. The projected CAGR for the next 4 years is 63%.

Back to Top